Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors – a single Brazilian center experience

OBJECTIVE: The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced differentiated thyroid carcinoma (DTC) refractory to radioactive iodine (RAIR) therapy. SUBJECTS AND METHODS: We reviewed the records of all patients with MKI-treated DTC...

Descripción completa

Detalles Bibliográficos
Autores principales: Treistman, Natalia, Nobre, Gabriela Maia, Tramontin, Mariana Yoshii, da Silva, Gabriel Madeira Werberich, Herchenhorn, Daniel, Araujo, Luiz Henrique de Lima, de Andrade, Fernanda Accioly, Corbo, Rossana, Bulzico, Daniel, Vaisman, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522180/
https://www.ncbi.nlm.nih.gov/pubmed/33939907
http://dx.doi.org/10.20945/2359-3997000000364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522180/
https://www.ncbi.nlm.nih.gov/pubmed/33939907
http://dx.doi.org/10.20945/2359-3997000000364

Ejemplares similares